COVID-19 is influencing everyday pharma activities. F2F visits are restricted, but life science companies still need to build a well-defined communication with doctors and engage them actively. That’s why the industry is looking for alternative ways to stay in touch with the HCPs and minimize health risks for both med reps and doctors.
Pharma considers remote visits as a very viable alternative communication channel. Earlier this solution has already shown itself as cost-efficient, effective and fast.
Here’s what you can get launching remote visits now:
- minimum risks to health and business during the epidemic
- no geographical or time barriers between you and the HCP
- 4x times increased frequency of visits and their duration
- quick & effortless, on-the-go project launch
Watch the webinar recording to find out more about how to build long-distance customer relationships during a worldwide pandemic with the help of reliable and secure online meetings platform designed specifically for Life Sciences.
Request the recording absolutely for free by submitting a simple form below and we will send you the link to the video to your email box.
